RBF Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$787K Hold
25,000
0.04% 322
2025
Q4
$737K Hold
25,000
0.03% 344
2025
Q3
$631K Hold
25,000
0.03% 375
2025
Q2
$600K Hold
25,000
0.03% 395
2025
Q1
$573K Hold
25,000
0.03% 377
2024
Q4
$633K Sell
25,000
-4,798
-16% -$122K 0.03% 353
2024
Q3
$743K Hold
29,798
0.04% 343
2024
Q2
$884K Hold
29,798
0.05% 288
2024
Q1
$898K Hold
29,798
0.05% 302
2023
Q4
$853K Hold
29,798
0.05% 299
2023
Q3
$1.1M Hold
29,798
0.07% 247
2023
Q2
$1.16M Hold
29,798
0.07% 249
2023
Q1
$1.09M Hold
29,798
0.08% 236
2022
Q4
$918K Buy
+29,798
New +$925K 0.07% 249

Other funds holding RTO

RBF Capital's RTO Position: Q1 2026 in Review

RBF Capital held its Rentokil (RTO) position steady in Q1 2026 at 25,000 shares worth $787K. The position accounts for 0.04% of the portfolio, ranked #322.

RBF Capital first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.16M in Q2 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • RBF Capital held 25,000 shares of Rentokil worth $787K as of Q1 2026.
  • RBF Capital left its Rentokil share count unchanged in Q1 2026.
  • Rentokil made up 0.04% of RBF Capital's portfolio in Q1 2026, its #322 holding.
  • RBF Capital first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • RBF Capital's Rentokil position peaked at $1.16M in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.